| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGYNO.2020.09.011 |
| P698 | PubMed publication ID | 32951891 |
| P50 | author | Beryl L. Manning-Geist | Q92593284 |
| P2093 | author name string | Michael G Muto | |
| Whitfield B Growdon | |||
| Neil S Horowitz | |||
| Marcela G Del Carmen | |||
| Michael J Worley | |||
| Andrea Pelletier | |||
| Rachel M Clark | |||
| Mackenzie W Sullivan | |||
| Alexa N Kanbergs | |||
| P2860 | cites work | Obesity in anaesthesia and intensive care | Q22066078 |
| Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly | Q35214119 | ||
| Postoperative complications in obese and nonobese patients | Q36587633 | ||
| Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. | Q39405578 | ||
| Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. | Q39902180 | ||
| Aggressive and complex surgery for advanced ovarian cancer: an economic analysis | Q40025780 | ||
| Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer | Q40351106 | ||
| Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. | Q41721778 | ||
| Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer | Q44461877 | ||
| Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer | Q58119464 | ||
| A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model | Q80549677 | ||
| Defining the limits of radical cytoreductive surgery for ovarian cancer | Q85014716 | ||
| Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery? | Q86044365 | ||
| Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review | Q89180680 | ||
| Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness | Q89367534 | ||
| A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome | Q91975002 | ||
| Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer | Q92551368 | ||
| P921 | main subject | ovarian cancer | Q172341 |
| P577 | publication date | 2020-09-18 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancer |
Search more.